JPWO2022009698A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022009698A5
JPWO2022009698A5 JP2022535021A JP2022535021A JPWO2022009698A5 JP WO2022009698 A5 JPWO2022009698 A5 JP WO2022009698A5 JP 2022535021 A JP2022535021 A JP 2022535021A JP 2022535021 A JP2022535021 A JP 2022535021A JP WO2022009698 A5 JPWO2022009698 A5 JP WO2022009698A5
Authority
JP
Japan
Prior art keywords
residue
pharma
acceptable salt
group
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022535021A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022009698A1 (https=
JP7740715B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/024125 external-priority patent/WO2022009698A1/ja
Publication of JPWO2022009698A1 publication Critical patent/JPWO2022009698A1/ja
Publication of JPWO2022009698A5 publication Critical patent/JPWO2022009698A5/ja
Application granted granted Critical
Publication of JP7740715B2 publication Critical patent/JP7740715B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022535021A 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体 Active JP7740715B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020116583 2020-07-06
JP2020116583 2020-07-06
PCT/JP2021/024125 WO2022009698A1 (ja) 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体

Publications (3)

Publication Number Publication Date
JPWO2022009698A1 JPWO2022009698A1 (https=) 2022-01-13
JPWO2022009698A5 true JPWO2022009698A5 (https=) 2024-07-02
JP7740715B2 JP7740715B2 (ja) 2025-09-17

Family

ID=79553070

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022535021A Active JP7740715B2 (ja) 2020-07-06 2021-06-25 ペプチドおよびそれを含む複合体

Country Status (2)

Country Link
JP (1) JP7740715B2 (https=)
WO (1) WO2022009698A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1864996A1 (en) * 2006-06-06 2007-12-12 Helmholtz-Zentrum für Infektionsforschung GmbH Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker.
JP6143270B2 (ja) * 2013-01-31 2017-06-07 学校法人東京薬科大学 マイオスタチン阻害ペプチド
ES2870085T3 (es) * 2013-06-26 2021-10-26 Xigen Inflammation Ltd Inhibidores peptídicos permeables a células de la ruta de transducción de señales de JNK para el tratamiento de la cistitis
GB201410507D0 (en) * 2014-06-12 2014-07-30 Univ Bath Drug delivery enhancement agents
WO2018030432A1 (ja) * 2016-08-10 2018-02-15 学校法人東京薬科大学 ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ
JP2020059663A (ja) * 2018-10-09 2020-04-16 学校法人東京薬科大学 ペプチドもしくはその薬学的に許容される塩、またはそれらのプロドラッグ

Similar Documents

Publication Publication Date Title
JP7411414B2 (ja) ペプチドの製造方法、及び塩基の処理方法
JP6703668B2 (ja) ペプチド合成方法
CN1154655C (zh) k受体的阿片样肽
JP2014507402A5 (https=)
JP2009537624A5 (https=)
CN108350009B (zh) 具有口服生物利用率的五氮杂大环状环络合物
JP2019043957A5 (https=)
JP2014530868A5 (https=)
FI3642340T3 (fi) Muunneltu l-asparaginaasi
JP2012500001A5 (https=)
JP2016521257A5 (https=)
JP6703669B2 (ja) リュープロレリンの製造方法
JP2016518351A5 (https=)
JP2019509280A5 (https=)
CA3004641A1 (en) Cyclic peptides targeting .alpha.4.beta.7 integrin
CA3182260A1 (en) Manufacture, formulation and dosing of apraglutide
JPWO2022009698A5 (https=)
TWI364291B (en) Peptidic vasopressin receptor agonists
JP2018521977A5 (https=)
JP2018519254A5 (https=)
JPS59170051A (ja) 薬理活性を有するトリペプチド誘導体
JP2014515595A5 (https=)
JP5647609B2 (ja) 経粘膜吸収性を付与したモチリン類似ペプチド化合物
JP2017512799A (ja) 環状プロサポシンペプチドおよびその使用
KR20250135270A (ko) 인터류킨-23 수용체의 지질화된 펩티드 억제제의 제형